Health news
Purified Cortrophin Gel (repository corticotropin injection USP) is now available for the treatment of certain chronic autoimmune disorders, including but not limited to acute exacerbations of multiple sclerosis, rheumatoid arthritis, and excess urinary protein due…
The Food and Drug Administration (FDA) has accepted the Biologics License Application for ublituximab for the treatment of patients with relapsing forms of multiple sclerosis. Ublituximab is an investigational glycoengineered monoclonal antibody that targets CD20,…
The Food and Drug Administration (FDA) has approved Lyvispah (baclofen) oral granules for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.…
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application for Purified Cortrophin® Gel (repository corticotropin injection) for the treatment of certain autoimmune disorders, including but not limited to acute exacerbations of…
Depression and attentional alterations are recurrent among patients with relapsing-remitting multiple sclerosis (RRMS), according to study results presented at the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), held October 25-28, 2021…
International consensus recommendations on the use of standardized magnetic resonance imaging (MRI) in multiple sclerosis (MS) developed by the Magnetic Resonance Imaging in MS (MAGNIMS) group, the Consortium of Multiple Sclerosis Centers (CMSC), and the…
The Food and Drug Administration has accepted for review the resubmitted supplemental New Drug Application for Purified Cortrophin® Gel (repository corticotropin injection) for multiple indications on its previously approved label, including but not limited to…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021